Septin 4, the Drosophila Ortholog of Human CDCrel-1, Accumulates in parkin Mutant Brains and is Functionally Related to the Nedd4 E3 Ubiquitin Ligase

被引:0
|
作者
Verónica Muñoz-Soriano
Rocío Nieto-Arellano
Nuria Paricio
机构
[1] Universidad de Valencia,Departamento de Genética, Facultad de CC Biológicas
来源
关键词
Septin 4; Parkin; Nedd4; E3 ubiquitin ligases; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Although most PD cases are sporadic, several loci have been involved in the disease. parkin (PARK) is causative of autosomal recessive juvenile Parkinsonism (ARJP) and encodes an E3 ubiquitin ligase associated with proteasomal degradation. It was proposed that loss of PARK function may lead to the toxic accumulation of its substrates in the brain, thus causing dopaminergic (DA) neuron death. Indeed, the first identified PARK substrate was CDCrel-1, a protein of the Septin family that accumulates in ARPJ brains. Drosophila has been used as a successful model organism to study PD broadly contributing to the understanding of the disease. Consistently, park mutant flies recapitulate some key features of ARJP patients. In this scenario, we previously reported that overexpression of Septin 4 (Sep4), the Drosophila ortholog of CDCrel-1, is toxic for DA neurons and interacts physically with Park, thus suggesting that Sep4 could be a Park substrate in Drosophila. Confirming this hypothesis, we show that Sep4 accumulates in park mutant brains as its human counterpart. Furthermore, we demonstrate that Nedd4, another E3 ubiquitin ligase that may have a role in PD, is functionally related to Sep4 and could be involved in regulating Sep4 subcellular localization/trafficking.
引用
收藏
页码:136 / 143
页数:7
相关论文
共 50 条
  • [1] Septin 4, the Drosophila Ortholog of Human CDCrel-1, Accumulates in parkin Mutant Brains and is Functionally Related to the Nedd4 E3 Ubiquitin Ligase
    Munoz-Soriano, Veronica
    Nieto-Arellano, Rocio
    Paricio, Nuria
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 (01) : 136 - 143
  • [2] Genetic screen to detect genes interacting with Septin 4, the Drosophila ortholog of human CDCrel-1
    Munoz-Soriano, Vernica
    Paricio, Nuria
    JOURNAL OF NEUROGENETICS, 2006, 20 (3-4) : 183 - 183
  • [3] Regulation of dendritic development by E3 ubiquitin ligase Nedd4
    Kawabe, Hiroshi
    Rhee, Jeong-Seop
    Katsurabayashi, Shutaro
    Neeb, Antje
    Umikawa, Masato
    Kariya, Ken-ichi
    Rosenmund, Christian
    Brose, Nils
    NEUROSCIENCE RESEARCH, 2007, 58 : S39 - S39
  • [4] A Role for the E3 Ubiquitin Ligase NEDD4 in Keloid Pathogenesis
    Marneros, Alexander G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (02) : 279 - 280
  • [5] The E3 ubiquitin ligase Nedd4/Nedd4L is directly regulated by microRNA 1
    Zhu, Jun-yi
    Heidersbach, Amy
    Kathiriya, Irfan S.
    Garay, Bayardo I.
    Ivey, Kathryn N.
    Srivastava, Deepak
    Han, Zhe
    King, Isabelle N.
    DEVELOPMENT, 2017, 144 (05): : 866 - 875
  • [6] Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy
    Li, Yuyin
    Zhang, Li
    Zhou, Jie
    Luo, Shenheng
    Huang, Rui
    Zhao, Changcai
    Diao, Aipo
    CELL PROLIFERATION, 2015, 48 (03) : 338 - 347
  • [7] NEDD4 E3 ligase: Functions and mechanism in human cancer
    Wang, Zhi-Wei
    Hu, Xiaoli
    Ye, Miaomiao
    Lin, Min
    Chu, Man
    Shen, Xian
    SEMINARS IN CANCER BIOLOGY, 2020, 67 : 92 - 101
  • [8] Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers
    Liangzi Cao
    Hao Li
    Xiaofang Liu
    Yubang Wang
    Bowen Zheng
    Chengzhong Xing
    Naijin Zhang
    Jingwei Liu
    BMC Cancer, 23
  • [9] The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer
    Weng, Min
    Luo, Zhu-Lin
    Wu, Xiao-Ling
    Zeng, Wei-Zheng
    ONCOTARGET, 2017, 8 (12) : 20288 - 20296
  • [10] Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers
    Cao, Liangzi
    Li, Hao
    Liu, Xiaofang
    Wang, Yubang
    Zheng, Bowen
    Xing, Chengzhong
    Zhang, Naijin
    Liu, Jingwei
    BMC CANCER, 2023, 23 (01)